IL17A and myeloid sarcoma: The increased expression of lncRNA-NEAT1 is directly linked to tumor necrosis factor (TNF-α) associated with helper T cell 1 (Th1) and interleukin 17 (IL-17) related to helper T cell 17 (Th17), thereby enhancing vulnerability to MS.